483
Brock A. Andersen, M.D.FDA 483 - Brock A. Andersen, M.D. - May 20, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Brock A. Andersen, a clinical investigator in Fruitland, ID, was cited for significant deviations during a human clinical study of an investigational drug. The inspection revealed failures in adhering to the investigational plan, including issues with subject eligibility, study drug storage and administration, and other protocol deviations. Additionally, the firm failed to maintain adequate and accurate case histories and informed consent documents.
Open in Dashboard
ID · 8fd8e161-9168-4e34-b5af-82ee7c066392